ADAPT Phase 2

计划入组 489 人

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

计划入组 403 人 · 首次发布于 2017 年 3 月 13 日

Continuous Dual Aspiration Technique With Zoom System for Stroke

计划入组 750 人 · 首次发布于 2026 年 3 月 25 日

AdAPT-002

AdAPT-PSV(EpicentRx)

SNA018

Adapt Produtos Oftalmológicos Ltda

Brazil

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

Handok Gains Korean Approval for Doptelet to Treat ITP and CLD-Related Thrombocytopenia

WHO Marks 25 Years of Research4Life: Expanding Equitable Access to Scientific Knowledge Across 120 Countries

TGF-β Inhibitor Pipeline Expands with 25+ Companies Developing Novel Therapies for Cancer and Fibrosis